Key result
Coronary PRS was associated with prevalent CAD in Polish primary care, but added little discrimination over classical risk factors.
Why the study?
Most validation of cardiovascular polygenic risk scores derives from UK or Nordic biobanks. Their transferability to Central European populations and incremental value over classical risk factors in routine primary care remained unestablished.
Does adding an externally derived coronary polygenic risk score to classical risk factors or SCORE2 improve discrimination for prevalent cardiovascular disease and all-cause mortality in a Polish primary-care cohort?
Cross-Sectional (n=1,328)
Yes
Does adding an externally derived coronary polygenic risk score to classical risk factors or SCORE2 improve discrimination for prevalent cardiovascular disease and all-cause mortality in a Polish primary-care cohort?
While a FinnGen-derived coronary polygenic risk score transfers well to a Polish primary-care cohort and associates with prevalent CAD, it provides negligible incremental discrimination beyond classical cardiovascular risk factors or SCORE2.
Answers are grounded in this paper and cite their sources.
Coronary PRS adds negligible discrimination beyond classical factors or SCORE2 in Polish primary care; extends validation to new European cohorts but should not yet change practice.
BACKGROUND: Polygenic risk scores (PRS) promise improved cardiovascular risk stratification, but most validation derives from UK or Nordic biobanks. The transferability of these scores to Central European populations and their incremental value over classical risk factors in routine care remain unestablished. OBJECTIVES: To determine whether a coronary PRS derived from external European data transfers to a Polish primary-care population and adds discrimination for prevalent cardiovascular disease beyond classical risk factors. METHODS: In the nationwide Polish LIPIDOGEN2015 primary-care cohort, we derived PRS for coronary heart disease, myocardial infarction (MI) and stroke from FinnGen data with continuous shrinkage priors and applied them to imputed genotypes. We compared allele frequencies of 1397 unrelated participants with a non-Finnish European (NFE) reference and, in 1328 participants with clinical data, related the PRS to coronary artery disease (CAD), MI and stroke recorded at baseline and to a composite including death during follow-up, with and without classical risk factors or SCORE2. RESULTS: Allele frequencies correlated with the NFE reference (r = 0.97). Per standard deviation (SD), the coronary PRS was associated with prevalent CAD (odds ratio 1.36, 95% CI 1.11 to 1.67) and the composite endpoint (1.26, 95% CI 1.04 to 1.51), as were two validated genome-wide scores. Adding it to classical risk factors changed the area under the curve (AUC) for the composite endpoint by 0.0017 (95% CI -0.0005 to 0.0076), from 0.860 to 0.861; results with SCORE2 were similar. The study had 80% power for odds ratios per SD of 1.31 (CAD) and 1.27 (composite). CONCLUSIONS: A coronary PRS derived from external European data retains its association with prevalent CAD without re-derivation in this Polish primary-care cohort but, in this cross-sectional, event-limited sample, adds little discrimination to classical risk factors. Its value for predicting future events in this setting remains to be tested against incident outcomes.
No takes yet. Share an insight, caveat, or question.
Banach et al. (2026) conducted a cross-sectional in Cardiovascular disease / Coronary artery disease (n=1,328). Coronary polygenic risk score (PRS) per 1-SD increase vs. Classical cardiovascular risk factors / SCORE2 alone was evaluated on Prevalent coronary artery disease (CAD) (OR 1.36, 95% CI 1.11 to 1.67, p=0.003). Coronary PRS was associated with prevalent CAD in Polish primary care, but added little discrimination over classical risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: